- Home
- VKTX vs TREX Comparison
VKTX vs TREX Comparison
Compare VKTX & TREX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VKTX
- TREX
- Stock Information
- Founded
- VKTX 2012
- TREX 1996
- Country
- VKTX United States
- TREX United States
- Employees
- VKTX N/A
- TREX N/A
- Industry
- VKTX Biotechnology: Pharmaceutical Preparations
- TREX
- Sector
- VKTX Health Care
- TREX
- Exchange
- VKTX Nasdaq
- TREX Nasdaq
- Market Cap
- VKTX 4.7B
- TREX N/A
- IPO Year
- VKTX 2015
- TREX 1999
- Fundamental
- Price
- VKTX $41.49
- TREX $68.69
- Analyst Decision
- VKTX Strong Buy
- TREX Buy
- Analyst Count
- VKTX 12
- TREX 16
- Target Price
- VKTX $106.75
- TREX $79.94
- AVG Volume (30 Days)
- VKTX 3.6M
- TREX 1.4M
- Earning Date
- VKTX 02-05-2025
- TREX 02-24-2025
- Dividend Yield
- VKTX N/A
- TREX N/A
- EPS Growth
- VKTX N/A
- TREX 23.11
- EPS
- VKTX N/A
- TREX 2.19
- Revenue
- VKTX N/A
- TREX $1,179,567,000.00
- Revenue This Year
- VKTX N/A
- TREX $6.50
- Revenue Next Year
- VKTX N/A
- TREX $6.00
- P/E Ratio
- VKTX N/A
- TREX $31.53
- Revenue Growth
- VKTX N/A
- TREX 8.10
- 52 Week Low
- VKTX $17.23
- TREX $58.68
- 52 Week High
- VKTX $99.41
- TREX $101.91
- Technical
- Relative Strength Index (RSI)
- VKTX 35.23
- TREX 42.89
- Support Level
- VKTX $39.09
- TREX $68.52
- Resistance Level
- VKTX $43.48
- TREX $71.41
- Average True Range (ATR)
- VKTX 2.15
- TREX 2.11
- MACD
- VKTX 0.10
- TREX -0.76
- Stochastic Oscillator
- VKTX 28.04
- TREX 16.41
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.